NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save

Next deadline: Nov 12, 2021

Later deadlines: Feb 12, 2022, Mar 12, 2022, Jun 12, 2022, Jul 12, 2022, Oct 12, 2022, Nov 12, 2022, Feb 12, 2023, Mar 12, 2023, Jun 12, 2023, Jul 12, 2023, Oct 12, 2023, Nov 12, 2023, Feb 12, 2024, Mar 12, 2024, Jun 12, 2024, Jul 12, 2024

Grant amount: Up to US $150,000

Fields of work: Cancer/Oncology

Applicant type: Government Entity, Indigenous Group, Nonprofit, For-Profit Business, Postdoctoral Researcher, Doctor, Research Scientist

Funding uses: Clinical Behavioral, Clinical Biomedical

Location of project: United States

Location of residency: United States

Overview:

NOTE: Grant applications and associated documents (e.g., reference letters) are due by 5:00 PM local time of application organization on the specified due date.

  • New submission: February 12, June 12, October 12
  • Renewal, resubmission, revision submission: March 12, July 12, November 12

The purpose of the NCI Transition Career Development Award to Promote Diversity (K22) is to assist postdoctoral fellows or individuals in equivalent positions to transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.

This Funding Opportunity Announcement (FOA) is a continuation of the NCI Transition Career Development Award to Promote Diversity (K22) to enhance the diversity in the NCI-funded cancer research workforce by supporting eligible individuals from diverse backgrounds, including groups that have been shown to be nationally underrepresented in the biomedical, behavioral, social and clinical sciences. This award will provide "protected time" through salary and research support for 3 years beginning at the time when the candidate starts a tenure-track faculty position.

This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (PAR-21-301).

You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed September 17, 2021 and last updated September 17, 2021